United States In Vivo Toxicology Market 2025 | Growth Drivers, Key Players & Investment Opportunities

Market Size and Growth

Global in vivo toxicology market growing at a Higer CAGR during the forecast period 2024-2031.

Key Development:

United States: Recent Industry Developments

✅ July 2025: The FDA launched the New Alternative Methods Program, allocating $5 million to promote non-animal testing methods, aiming to replace, reduce, and refine animal use in regulatory assessments.

✅ June 2025: The EPA endorsed OECD Test Guidelines 487 and 488, facilitating the integration of in vitro micronucleus assays and transgenic rodent gene mutation assays into pesticide safety evaluations.

✅ May 2025: The National Toxicology Program (NTP) initiated collaborations with the Tox21 Consortium to enhance predictive toxicology through high-throughput screening and data integration.

Japan: Recent Industry Developments

✅ April 2025: Japanese researchers developed an enhanced thymidine kinase (TK) gene mutation assay, improving detection sensitivity for genotoxicity assessments in pharmaceuticals and chemicals.

✅ February 2025: The Japanese Society of Toxicology highlighted the rise of predictive toxicology, integrating microRNA, epigenetic, and systems toxicology to assess a vast array of chemical substances efficiently.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/in-vivo-toxicology-market?sb

In vivo toxicology is the study of the adverse effects of chemicals, drugs, or other substances on living organisms, typically conducted using animal models. It helps evaluate the safety, dosage, and potential health risks of compounds before human exposure. By providing critical insights into biological responses, in vivo toxicology plays a key role in drug development, regulatory compliance, and environmental safety assessment.

Recent Mergers and Acquisitions

✅ June 2025: AbbVie acquired Capstan Therapeutics for $2.1 billion, enhancing its capabilities in cell and gene therapy through Capstan's in vivo CAR-T platform and RNA delivery technology.

✅ May 2025: Eli Lilly announced the acquisition of Verve Therapeutics for $1.3 billion, advancing its genetic medicine strategy to address cardiovascular risk factors.

✅ March 2025: AstraZeneca acquired a cell therapy company for up to $1 billion, aiming to advance in vivo cancer treatments and the future of cell therapy.

Key Players:

-> MATTEK CORPORATION, Vimta Labs Ltd, Merck KGaA, NUVISAN GmbH, Charles River Laboratories, Eurofins Scientific, Nagi Bioscience, Labcorp Drug Development, PerkinElmer Inc, Taconic Biosciences among others.

Growth Forecast Projected:

The Global In Vivo Toxicology Market is anticipated to rise at a considerable rate during the forecast period, between 2024 and 2031. In 2023, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

Research Process:

Both primary and secondary data sources have been used in the global In Vivo Toxicology Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=in-vivo-toxicology-market

Key Segments:

By Product Type: Kits, Reagents, Equipments

By Test Type: Subchronic Toxicity Tests, Chronic Toxicity Tests, Carcinogenicity Tests, Others

By Technology: In vivo Imaging, In Silico Models, Omics Technologies, Others

By End User: Pharmaceutical and Biotechnology Companies, Contract Research Organizations (CROs), Academic and Research Institutions

Regional Analysis for In Vivo Toxicology Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Benefits of the Report:

Chapter 1: Sets the stage by outlining the report's coverage, summarizing key market segments by region, product type, and application. Presents a snapshot of market sizes, growth potential across segments, and anticipated industry evolution both short and long term.

Chapter 2: Highlights pivotal market insights and uncovers the most significant emerging trends driving change within the industry.

Chapter 3: Offers an in-depth look at the competitive landscape among In Vivo Toxicology producers, including revenue shares, strategic moves, and recent mergers and acquisitions.

Chapter 4: Presents comprehensive profiles of the market's key players, delving into details such as revenue, profit margins, product portfolios, and company milestones.

Chapters 5 & 6: Analyze In Vivo Toxicology revenue at both regional and country levels, providing quantitative breakdowns of market sizes, growth opportunities, and development prospects worldwide.

Chapter 7: Focuses on different market segments by type, examining their individual sizes and potential, guiding readers toward high-impact, untapped market areas.

Chapter 8: Explores segmentation by application, evaluating industry growth potential in various downstream markets and pinpointing promising sectors for expansion.

Chapter 9: Provides a thorough review of the industry's supply chain mapping out both upstream and downstream activities.

Chapter 10: Concludes with a summary of the report's key findings and highlights the most critical takeaways for industry stakeholders.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/in-vivo-toxicology-market?sb

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?sb

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg?sb

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.